Jonny Sågänger
Editor, Pharma Market and Digital Health Newsletter
Bonnier Business Media Sweden
24 November 2026
7.00 - 8.00 CET
Registration and Networking Breakfast
8.00 - 8.10 CET
CHAIR'S WELCOME AND OPENING REMARKS
Manufacturing and Quality
Supply Chain
8.10 - 8.40 CET
KEYNOTE
Sarah Dayre
SVP, EMEA Supply and Sweden Operations
AstraZeneca
Integrating Automation Technologies to Improve End-to-end Supply Chain Visibility and Efficiency in Biomanufacturing Networks
- Optimizing planning and inventory management through real-time data integration across distribution systems
- Reducing supply variability and bottlenecks by automating procurement, scheduling, and logistics coordination processes
- Implementing scalable automation solutions that support agile supply chain adaptation across fluctuating demand and production volumes
- Enhancing supply chain reliability by minimizing manual interventions in order processing, tracking, and fulfillment workflows
- Leveraging advanced analytics and AI to improve demand forecasting, capacity planning, and supply risk detection
- Strengthening supplier collaboration through automated data exchange and integrated digital supply chain platforms
- Training teams on supply chain-critical aspects of operating automated systems
8.40 - 9.10 CET
Plenary
Tongtong Wang
SVP and Global Head, Pharma Technical Development
Roche
Transforming Science into Scalable Manufacturing and Designing Systems That Deliver Innovation
- Engineering end-to-end process design frameworks that translate scientific breakthroughs into manufacturable, high-quality therapies
- Developing robust control systems that ensure precision, compliance, and consistency across global manufacturing networks
- Applying advanced analytics to deepen process understanding and accelerate scale-up readiness
- Embedding Quality by Design principles into every phase of technical development and manufacturing execution
- Strengthening integration between technical development, operations, and supply chain to enable seamless technology transfer
- Building adaptable manufacturing platforms that support emerging modalities and evolving market needs
9.10 - 9.40 CET
Plenary
Enhancing Analytical Testing to Ensure Product Safety
- Implementing rigorous analytical testing protocols to ensure the safety and efficacy of bioproducts
- Developing new testing methods to detect impurities and contaminants in biopharmaceuticals
- Validating analytical testing procedures to meet regulatory standards and ensure compliance
- Optimizing testing workflows to reduce turnaround times and increase lab efficiency
- Training laboratory personnel on the latest analytical techniques and best practices
- Collaborating with external labs to ensure consistency and accuracy in analytical testing results
9.45 - 11.25 CET
REFRESHMENTS, NETWORKING, AND PRE-ARRANGED 1-2-1 MEETINGS
11.30 - 12.00 CET
Sessions
Manufacturing and Quality
Cheryl Crain
SVP and Global Head, Quality Assurance and Quality Control
Alnylam
Driving Quality, Innovation, and Excellence Across Global Biomanufacturing Networks
- Strengthening a global quality assurance and control framework to ensure consistent reliability across RNAi manufacturing
- Adopting a risk-based quality approach that balances tight oversight with agile development timelines
- Upgrading analytical and QC capabilities to match the complexity of advanced RNAi modalities
- Driving a culture of quality excellence through leadership engagement, cross-functional collaboration, and continuous training
- Using digital tools and automation to boost data integrity, streamline deviation handling, and support smarter quality decisions
- Building quality systems on a global scale to support the future growth of RNAi therapies as they reach more patients
Supply Chain
Ulla Grove Krogsgaard Thomsen, Ph.D.
Chief Executive Officer
Novo Nordisk Pharmatech A/S
Opportunities and Challenges Scaling Stem Cells for Therapeutic Use
- Exploring the evolving demand for stem cell-based therapies and its implications on biomanufacturing capacity and infrastructure
- Addressing critical scale-up bottlenecks in stem cell production, including consistency, quality control, and regulatory compliance
- Leveraging advanced raw materials, enzymes, and process innovations to enable robust and reproducible cell manufacturing
- Designing flexible, scalable manufacturing platforms to support the transition from clinical to commercial-scale regenerative therapies
- Integrating supply chain resilience and strategic capacity expansion to meet rising global demand for advanced therapies
- Driving collaboration across industry partners to accelerate innovation and standardization in next-generation biomanufacturing ecosystems
12.05 - 12.35 CET
WORKSHOP
Room 1
Speaker TBA
CG Pharma & Biotech
Elevating Quality Standards in Biomanufacturing with High-Purity Chemicals and Precision Processing
- Ensuring consistency in biomanufacturing by adhering to strict GMP and ISO-certified quality management systems
- Minimizing contamination risks through advanced purification techniques and precision-controlled chemical processing
- Enhancing batch-to-batch reproducibility by leveraging cutting-edge analytical testing and validation protocols
- Strengthening process control with digital monitoring tools to maintain real-time oversight of chemical formulations
Room 2
Speaker TBA
Bluecrux
Enhancing Supply Chain Performance: how a top 10 life sciences company aligned global QC and SC functions with AI-driven scheduling and planning
- Transitioning QC from manual scheduling to automated planning, improving efficiency and lead times
- Integrating QC planning with global Supply Chain, improving coordination and responsiveness
- Automating scheduling to provide real-time insights into QC operations, thus enabling agility and predictable product releases
- Harmonizing and standardizing QC processes across global sites to facilitate synchronized QC-Supply Chain workflows
- Leveraging AI-driven capacity forecasting to align QC capacity with Supply Chain demands, reducing bottlenecks and optimizing inventory management
- Future-proofing their QC strategy by placing Binocs at the core of their vision for fully integrated, AI-driven QC operations by 2030
12.40 - 13.40 CET
Lunch and Learn Roundtables
Speaker TBA
Lonza
Maximizing Bioprocess Yield and Efficiency with Advanced Mixing Strategies
Speaker TBA
VivaBioCell
Scaling Cell Therapy Manufacturing From Manual Processes to Automated, Closed-System Production
Accelerating Production Goals Through Targeted Process Optimization
Optimizing Aseptic Fill and Finish to Ensure Product Integrity
13.45 - 14.15 CET
Sessions
Manufacturing and Quality
Cagdas Celik
Global Vice President, Head of Engineering & Technology
Johnson & Johnson
Enabling Scalable and Digital Biomanufacturing Through Engineering Excellence
- Transforming biomanufacturing operations through integrated engineering and technology strategies that improve speed, quality, and reliability
- Deploying digital tools and smart manufacturing systems to increase visibility and support real-time decision-making across sites
- Standardizing engineering and validation processes to ensure consistent compliance in regulated biologics environments
- Accelerating technology transfer from development to manufacturing to shorten time-to-market for new therapies
- Integrating automation and data analytics to improve efficiency, reduce variability, and support scalable production
- Strengthening collaboration between engineering, quality, and operations teams to support global manufacturing performance
Supply Chain
Ferhat Zatsan
SVP, Global Strategy & Operations
Ceva Santé Animale
Revolutionizing Cell Therapy Supply Chains for Scalable Manufacturing Success
- Building flexible manufacturing networks capable of supporting commercial-scale cell therapy demand across global markets
- Using automation and digital orchestration tools to improve coordination between manufacturing sites, logistics providers, and clinical partners
- Maintaining product integrity during transport by strengthening cold chain infrastructure and real-time shipment monitoring
- Navigating the operational complexity of vein-to-vein delivery while reducing turnaround times for patient-specific therapies
- Creating stronger partnerships with suppliers to improve material availability, traceability, and long-term supply continuity
- Balancing rapid innovation with evolving regulatory expectations surrounding handling, distribution, and chain-of-identity requirements
14.20 - 14.50 CET
Workshops
Room 1
Speaker TBA
Lonza
Optimising Bioprocess Performance Across Mixing and Scale-Up Strategies
- Maximising bioprocess yield and efficiency through mixing approaches that support uniform nutrient distribution and consistent cell growth
- Evaluating orbital mixing alongside traditional stirred-tank systems to understand impacts on shear, complexity and process control
- Enhancing upstream performance by improving cell viability and product titres through gentle, well-controlled fluid dynamics
- Supporting seamless scale-up from bench to commercial production while maintaining consistent hydrodynamic conditions
- Reducing shear stress to protect sensitive cell cultures and improve repeatability across production runs
- Applying insights from single-use and alternative mixing technologies to enable flexible, scalable biomanufacturing processes
Room 2
Speaker TBA
DrM
Advancing Separation and Mixing Strategies for Robust Bioprocessing
- Exploring solid-liquid separation challenges in upstream/downstream bioprocesses and how tailored solutions address them
- Comparing vibratory mixing versus traditional stirred-tank systems to improve homogeneity and reduce shear stress
- Evaluating single-use filtration systems for cell harvest and clarification to accelerate campaign turnover
- Scaling pilot filtration and mixing technologies from lab to commercial-scale while maintaining process integrity
- Reducing operational risk through closed systems, low-shear mixing and footprint-efficient modular solutions
- Embedding real-world case studies from biopharma to draw actionable lessons on performance, cost and compliance
14.55 – 16.15 CET
Happy Hour and Pre-Arranged 1-2-1 Business Meetings
16.20 - 16.50 CET
Sessions
Manufacturing and Quality
Fabrice Etienne
VP, Vector and External Manufacturing Operations
Bristol Myers Squibb
Building Resilient Pathways for the Next Generation of Advanced Therapies
- Driving scalable approaches to support the growth of advanced therapies
- Optimizing collaborative manufacturing ecosystems to improve agility and capacity
- Navigating evolving European regulatory frameworks to enable timely patient access
- Leveraging cross-industry partnerships to foster innovation and shared capabilities
- Implementing digital tools to enhance transparency and operational efficiency
- Strengthening supply chain resilience to mitigate risk and ensure continuity
Supply Chain
Bhaps Bagar
VP, Supply Chain Tech and Smart Manufacturing
GSK
Transforming Biopharmaceutical Supply Chains with Digital Twins
- Implementing digital twin models to simulate and optimize manufacturing processes
- Enhancing real-time visibility and predictive decision-making across the supply chain
- Integrating smart automation and IoT-enabled monitoring to reduce variability and downtime
- Ensuring regulatory compliance and product quality within connected digital frameworks
- Driving collaboration between manufacturing, QA/QC, and supply chain teams for end-to-end operational excellence
- Scaling operations efficiently to support growing biologics pipelines and patient demand
16.50 - 17.20 CET
Plenary
Florence Brunel Veilleux, Ph.D.
SVP and Global Head, MSAT
Sanofi
Streamlining Process Optimization to Boost Production Efficiency
- Identifying bottlenecks in manufacturing processes and implementing solutions for increased efficiency
- Leveraging process analytics to monitor performance and drive continuous improvement initiatives
- Implementing lean manufacturing principles to reduce waste and enhance productivity
- Standardizing processes across multiple manufacturing sites to ensure consistency and scalability
- Incorporating advanced automation and digital tools to streamline biomanufacturing workflows
- Fostering a culture of continuous improvement to drive long-term operational excellence
17.20 - 18.05 CET
PANEL DISCUSSION
Maureen Larkin
Executive Director and Site Lead, College Park
Alexion
Geoffrey Pot
SVP, Global Manufacturing Sciences and Technology
Takeda
Hans-Peter Grau
SVP and Head, Global Biotech Manufacturing
Merck KGaA
Mo Behbahani
VP, Site Head and General Manager, Parenteral Drug Product and Device Manufacturing
Eli Lilly
Speaker TBA
L7 InformaticsBhaps Bagar
VP, Supply Chain Tech and Smart Manufacturing
GSK
From Innovation to Execution: Enabling Scalable Agile and Tech Forward Biomanufacturing
- Aligning early stage innovation with long term manufacturing scalability
- Balancing flexibility and standardization as the next generation of biomanufacturing infrastructure evolves
- Integrating digital tools such as AI, digital twins, and MES for accelerated tech transfer and process optimization
- Leveraging CDMO partnerships to ensure agility and execution at scale
- Addressing talent gaps by building digitally fluent cross functional teams to support modern biomanufacturing
- Navigating risks and success factors in scaling novel therapies
18.05 - 18.10 CET
CHAIR'S CLOSING REMARKS
Manufacturing and Quality
Jonny Sågänger
Editor, Pharma Market and Digital Health Newsletter
Bonnier Business Media Sweden
Supply Chain
18.10 – 19.10 CET
NETWORKING DRINKS RECEPTION
Unlock Exclusive Summit Details
Exclusive summit content is reserved for qualified participants—request access today or enter your password.
